We proposed here that in response to transient cerebral ischemia combined with Aβ infusion, AT2 receptor signaling activated by damaged cerebral vessel could act as a crucial blocker for RAGE expression and activation to prevent Aβ excess in the brain contributing to inhibition of cognitive decline. Here, AGTR2 is linked to transient ischemic attack.